Key diagnostic criteria for adolescent polycystic ovary syndrome adjusted for age-specific hormonal and metabolic status standard


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. To specify the diagnostic criteria, clinical and laboratory features of PCOS in female adolescents. Materials and methods. The study comprised 130 girls aged 15 to 17 years with PCOS diagnosed by the Rotterdam criteria. The control group consisted of 30 healthy girls of a similar age with a regular menstrual cycle. The study participants underwent a complete clinical and laboratory workup with an expanded hormonal prof ile and a pelvic ultrasound examination. Results. Highly specific PCOS markers in girls aged 15-17 years include oligo- or amenorrhea with menarche and hirsutism, an ovarian volume of both ovaries > 10.70 cm3, ovarian-uterine index > 3.95, LH/FSH ratio> 1.23, AMH level> 7.20 ng/ml, testosterone > 1.15 nmol /L, and androstenedione > 11.45 ng/ml with a free androgen index > 2.75 (for each criterion, sensitivity and specificity is 75.0-93.0% and 0 83.0-93.0%, respectively). The diagnostic accuracy of PCOS reaches 92% with the logistic regression equation as follows: logit = 85.73- (1.73 x AMH) - (0.12 x Leptin) less than 70.72. Conclusion. The study determined threshold levels of AMH, free androgen index, androstenedione, testosterone, LH/FSH, values of ovarian volume and ovarian-uterine index, which have high sensitivity and specif icity and may be recommended for the diagnosis of PCOS in patients aged 15 - 17 years.

Full Text

Restricted Access

About the authors

Elena P. Khashchenko

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: khashchenko_elena@mail.ru
Candidate of Medical Sciences, Researcher 2nd gynecological department (gynecology of children and adolescents)

Elena V. Uvarova

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: elena-uvarova@yandex.ru
MD, professor, head of the 2nd gynecological department (gynecology of children and adolescents)

Tatyana Y. Ivanets

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: t_ivanets@oparina4.ru
MD, Head of the Clinical Diagnostic Laboratory

Fatima Sh. Mamedova

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: mamedova_f@mail.ru
candidate of medical sciences, doctor of the department of ultrasound diagnostics in neonatology and pediatrics

Mikhail Y. Vysokikh

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: m_vysokikh@oparina4.ru
candidate of biological sciences, Head. mitochondrial medicine laboratory

Pavel I. Borovikov

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: p_borovikov@oparina4.ru
Head. bioinformatics laboratory

Ivan S. Balashov

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: i_balashov@oparina4.ru
specialist of the bioinformatics laboratory

References

  1. Уварова Е.В. Детская и подростковая гинекология. Руководство для врачей. М.: Литтерра; 2009. 238 с.
  2. Yetim A., Yetim Q., Bag F., Erol O.B., Qig G., Ugar A. et al. Anti-Mullerian hormone and inhibin-A, but not inhibin-B or insulin-like peptide-3, may be used as surrogates in the diagnosis of polycystic ovary syndrome in adolescents: preliminary results. J. Clin. Res. Pediatr. Endocrinol. 2016; 8(3): 288-97. http:// dx.doi.org/10.4274/jcrpe.3253.
  3. Tsikouras P., Spyros L., Manav B., Zervoudis S., Poiana C., Nikolaos T. et al. Features of polycystic ovary syndrome in adolescence. J. Med. Life. 2015; 8(3): 291-6.
  4. Goodman N.F., Cobin R.H., Futterweit W., Glueck J.S., Legro R.S., Carmina E. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome. Endocr. Pract. 2015; 21(11): 1291-300. http:// dx.doi.org/10.4158/EP15748.DSC.
  5. Dumesic D.A., Oberfield S.E., Stener-Victorin E., Marshall J.C., Laven J.S., Legro R.S. Scientific statement on the diagnostic criteria,epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr. Rev. 2015; 36(5): 487-525. http://dx.doi.org/10.1210/er.2015-1018.
  6. Solomon C.G., Hu F.B., Dunaif A., Rich-Edwards J., Willett W.C., Hunter D.J. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA. 2001; 286(19): 2421-6.
  7. Fauser B.C., Tarlatzis B.C., Rebar R.W., Legro R.S., Balen A.H., Lobo R. et al. Consensus on women’s health. Aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS. Consensus Workshop Group. Fertil. Steril. 2012; 97: 28-38. http://dx.doi.org/10.1016/j. fertnstert.2011.09.024.
  8. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W. et al. The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 2009; 91(2): 456-88. http://dx.doi.org/10.1016/j.fertnstert.2008.06.035.
  9. Pinola P., Piltonen T.T., Puurunen J., Vanky E., Sundstrom-Poromaa I., Stener-Victorin E. et al. Androgen profile through life in women with polycystic ovary syndrome: A Nordic Multicenter Collaboration Study. J. Clin. Endocrinol. Metab. 2015; 100(9): 3400-7. http://dx.doi.org/10.1210/jc.2015-2123.
  10. Legro R.S., Arslanian S.A., Ehrmann D.A., Hoeger K.M., Murad M.H., Pasquali R. et al. Diagnosis and treatment of polycystic ovary syndrome: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2013; 98(12): 4565-92. http://dx.doi.org/10.1210/jc.2013-2350.
  11. Merino P.M., Villarroel С., Jesam C., Lopez P., Codner E. New diagnostic criteria of polycystic ovarian morphology for adolescents: impact on prevalence and hormonal profile. Horm. Res. Paediatr. 2017; 88(6): 401-7. http://dx.doi. org/10.1159/000481532.
  12. Демидов В.Н., Зыкин Б.И. Ультразвуковая диагностика в гинекологии. М.: Медицина; 1990. 224 с.
  13. GUdUcUa N., Kutayb S.S., Gormugc U., Kavakd Z.N., Dundera I. High DHEAS/ free testosterone ratio is related to better metabolic parameters in women with PCOS. Gynecol. Endocrinol. 2015; 31(6): 495-500. http://dx.doi.org/10.3109/ 09513590.2015.1022862.
  14. Чернуха Г.Е., Блинова И.В., Купрашвили М.И. Эндокринно-метаболические характеристики больных с различными фенотипами синдрома поликистозных яичников. Акушерство и гинекология. 2011; 2: 70-6.
  15. Буралкина Н.А., Уварова Е.В. Параметры овариального резерва девочек 15-17 лет с гармоничным половым и физическим развитием. Репродуктивное здоровье детей и подростков. 2010; 32(3): 20-8.
  16. Григоренко Ю.П., Уварова Е.В., Огрызкова В.Л., Ашрафян Л.А. Эхографические маркеры синдрома поликистозных яичников у девочек-подростков по данным комплексной трехмерной трансректальной эхографии. Гинекология. 2015; 17(2): 77-80.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies